Skip to main content

and
  1. Article

    Open Access

    Targeting polo-like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma

    Adrenocortical carcinoma (ACC) is an aggressive cancer with a 5 year survival rate of 20–30 %. Various factors have been implicated in the pathogenesis of ACC including dysregulation of the G2/M transition and...

    Kimberly J. Bussey, Aditi Bapat, Claire Linnehan in Clinical and Translational Medicine (2016)